Reginald M. Gorczynski

Prof. Dr. Reginald M. Gorczynski

Institute of Medical Sciences, Depts. of Surgery and Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
+1
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2004 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski
ZCZhiqi Chen
Zhiqi Chen
YKYu Kai
Yu Kai
LLLydia Lee
Lydia Lee
SWSimon Wong
Simon Wong
PMPhilip A Marsden
Philip A Marsden
CD200Fc, a chimeric molecule including the extracellular domain of CD200 and a murine IgG2a Fc region, regulates immune responses following engagement of a cell surface receptor, CD200R, expressed on cells of the myeloid and T cell lineage. A recent report focused attention on a family of CD200Rs, but concluded that only one member used CD200 as its ligand. We have also cloned and sequenced a family of CD200Rs, but identify an amino terminus to two of the three isoforms not recognized by previous researchers. We show by FACS, using FITC-labeled CD200Fc, that COS7 cells transfected with all CD200R isoforms bind CD200 as ligand, although the functional consequences of this binding likely differs between the different isoforms. mAbs directed against the CD200 R1/R4 isoforms altered IL-2/IL-4 cytokine production and suppressed CTL responses in a fashion comparable to CD200Fc, with a significantly lesser effect seen following addition of anti-CD200 R2/R3.

1 May 2005 in Transplantation
Verified
Journal Article
Closed access
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski
LLLydia Lee
Lydia Lee
IBIvo Boudakov
Ivo Boudakov
CD200 is a transmembrane protein delivering immunoregulatory signals after engagement of CD200R. A family of CD200Rs exist (CD200R1–4) with different tissue expression and functional activity. In the presence of anti-CD200R2/3 monoclonal antibodies (mAbs), bone-marrow cells cultured in the presence of (interleukin [IL]-4+granulocyte-macrophage colony-stimulating factor) differentiate into dendritic cells (DCs), which induce CD4+CD25+Treg. The effect of these mAbs on Treg induced in anti-CD3 activated thymocyte cultures is unknown. BL/6 bone-marrow cells were cultured with GMC-SF and IL-4 in the presence/absence of anti-CD200Rs to generate DCs that induced Treg in C3H lymph-node T cells. Treg were also induced in anti–CD3/CD28-activated C3H thymocytes. Treg activity was assayed by (1) suppression of mixed leukocyte culture (MLC) in cultures using C3H stimulator spleen cells and BL/6 stimulator cells, and (2) by expression of the transcription factor, Foxp3. Addition of anti-CD200R2/3 mAbs (but not anti-CD200R1) to bone-marrow cultures led to generation of DCs that induced a CD4+CD25+ (Treg) population inhibiting MLCs (C3H cells stimulated with C57BL/6 cells) in a cytotoxic T–lymphocyte-associated antigen (CTLA)-4 and transforming growth factor (TGF)–β-dependent manner. Anti-CD200R2, but not anti-R1/R3, augmented induction of Foxp3-expressing Treg from anti-CD3/CD28 activated thymocytes. Suppression in MLCs by anti-CD200R1 mAbs was dependent on IL-10 and TGF-β. Unlike anti-CD200R1, anti-CD200R2 both promotes development of DCs with capacity to induce Treg and directly augments thymocyte production of Treg.

19 June 2002 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski
SHSima Hadidi
Sima Hadidi
GYGary Yu
Gary Yu
DCDavid A. Clark
David A. Clark

27 July 2007 in Transplantation
Verified
Journal Article
Closed access
IBIvo Boudakov
Ivo Boudakov
JLJian Liu
Jian Liu
NFNa Fan
Na Fan
PGPelin Gulay
Pelin Gulay
KWKarrie Wong
Karrie Wong
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski
Background. CD200:CD200R interactions deliver immunoregulatory signals. A family of CD200Rs (CD200R1-5) has been described, and engagement of CD200R1 by its ligand CD200 suppresses LPS-induced macrophage cytokine production, decreases alloimmune responses in vivo and in vitro, and suppresses collagen-induced arthritis. Methods. We generated C57BL/6 mice lacking the genomic exons encoding the extracellular domains of the CD200R1 molecule using transformation of ES cells and explored cell subtypes and immune responses in these mice. Results. Myeloid cells/splenocytes from CD200R1−/− mice were not stained in FACS by anti-CD200R1 mAb. Stimulation of splenic tumor necrosis factor-α production by lipopolysaccharide was enhanced relative to control (+/+) mice and was not suppressed by addition of exogenous CD200Fc. Modulation of alloreactivity in mixed leukocyte cultures by CD200Fc depended upon CD200R1+ stimulatory cells, although maximal immunoregulation by CD200Fc occurred only when CD200R1+ T responder cells also were used. CD200Fc failed to suppress graft rejection in CD200R1−/− mice. Conclusion. CD200:CD200R1 plays an immunoregulatory role in vivo.

15 February 2020
Verified
Book Chapter
Closed access
PDF file
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski

2 December 2009 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
Reginald M. GorczynskiReginald M. Gorczynski
Reginald M. Gorczynski
ZCZhiqi Chen
Zhiqi Chen
JDJun Diao
Jun Diao
IKIsmat Khatri
Ismat Khatri
KWKarrie Wong
Karrie Wong
JBJulia Behnke
Julia Behnke